AzTrials
AzTrials

Myopia, ProgressiveNCT07055815

Impact of Digital Screen Time in Progression of Myopia in Children

An observational study of Myopia, Progressive, run by Superior University at 1 site in Pakistan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Research suggests that prolonged digital screen time is a significant contributing factor to the progression of myopia in children. Studies have shown that increased near-work activities, such as reading, writing, and screen time, can lead to an increased risk of developing myopia. Read more about this study

Who is it for?
Ages 6 to 12 years
Conditions the study is for
Myopia, Progressive
What is being tested?
Progression of Myopia
How many people
79 participants
Where
1 sitePakistan
Study dates
17 Mar 2025to 28 Feb 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Impact of Digital Screen Time in Progression of Myopia in Children he widespread use of digital devices among children has raised concerns about the potential impact on their eye health. Excessive screen time can cause prolonged near focus, reduced outdoor time, and increased blue light exposure, all of which may contribute to myopia progression.

Who may be able to join

  • Both male and female myopic children of age 6 to 12 years were included with BCVA 6/6 with no any eye pathology.
  • No medication or disease that could affect vision.
  • Spherical equivalent of cylinder 0.50 to 1.00 were added.

Who cannot join

  • Opacity, cataract, any fundus pathologies, strabismus or indication of previous ocular surgeries were excluded.
  • High astigmatic children were excluded or more than 1.00DC.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Watan optical

    Lahore, Punjab Province

Other trials in Pakistan

About this study

Research suggests that prolonged digital screen time is a significant contributing factor to the progression of myopia in children. Studies have shown that increased near-work activities, such as reading, writing, and screen time, can lead to an increased risk of developing myopia. The widespread use of digital devices among children has raised concerns about the potential impact on their eye health.

Being tested
Progression of Myopia
Medical subject headings
Myopia, Degenerative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Progression of MyopiaDiagnostic test

    The widespread use of digital devices among children has raised concerns about the potential impact on their eye health. Excessive screen time can cause prolonged near focus, reduced outdoor time, and increased blue light exposure, all of which may contribute to myopia progression. Understanding the relationship between digital screen time and myopia progression is crucial for developing effective prevention and intervention strategies to mitigate the growing burden of myopia in children.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. self admistred questioner

    self admistred questioner to check Mild, moderate, and severe Myopia in Children

    Measured: 12 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jul 2025
  2. Study start17 Mar 2025
  3. Primary completion1 Sep 2025 (estimated)
  4. Study completion28 Feb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
79 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07055815
Sponsor's protocol ID
MSRSW/Batch-Fall23/831
Status last verified
Jun 2025
First submitted
28 Jun 2025
Last updated
9 Jul 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Myopia, Progressive, run by Superior University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 9 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

self admistred questioner (time frame: 12 Months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in